Financials

v3.24.4
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash $ 3,399 $ 6,760
Restricted cash 13
Receivables 38 46
Notes receivable 1,000
Related party receivable 14
Prepaid expenses and other current assets 151 199
Total current assets 3,602 8,018
Property and equipment, net 5
Operating lease right-of-use assets, net 63
Total assets 3,602 8,086
Current liabilities:    
Accounts payable 371 348
Note payable to related party 500
Other accrued liabilities 519
Operating lease liability, current 65
Deferred grant revenue 12
Total current liabilities 371 1,444
Total liabilities 371 1,444
Stockholders’ equity:    
Preferred stock, at amounts paid in, $0.001 par value per share; 5,000,000 shares authorized, 950,000 shares issued and outstanding at September 30, 2024 and December 31, 2023. 1 1
Common stock, at amounts paid-in, $0.001 par value per share; 225,000,000 shares authorized, 914,234 and 781,503 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively. 1 1
Additional paid-in capital 398,975 398,470
Accumulated deficit (395,746) (391,830)
Total stockholders’ equity 3,231 6,642
Total liabilities and stockholders’ equity $ 3,602 $ 8,086

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.24.4
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Total revenues $ 4 $ 184
Operating expenses:        
Research and development 424 1,426
General and administrative 754 1,641 3,891 4,104
Total operating expenses 754 2,065 3,891 5,530
Loss from operations (754) (2,061) (3,891) (5,346)
Other income (expense):        
Interest income (expense) (11) 1 18
Gain on asset sale 1,732 1,732
Other income (expense), net (9) 2 (26) (3)
Total other income (expense) (9) 1,723 (25) 1,747
Net loss $ (763) $ (338) $ (3,916) $ (3,599)
Basic net loss per common share $ (0.83) $ (0.45) $ (4.38) $ (4.79)
Diluted net loss per common share $ (0.83) $ (0.45) $ (4.38) $ (4.79)
Weighted average shares used in computing basic net loss per common share 914 751 894 751
Weighted average shares used in computing diluted net loss per common share 914 751 894 751
License [Member]        
Revenues:        
Total revenues $ 1
Grant [Member]        
Revenues:        
Total revenues $ 4 $ 183

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.24.4
CONDENSED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (3,916) $ (3,599)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on sale of assets (1,732)
Depreciation and amortization 5 109
Stock-based compensation 965
Other (2) (1)
Changes in operating assets and liabilities:    
Receivables 8
Notes receivable 1,000
Related party receivable (14)
Prepaid expenses and other assets 48 122
Accounts payable 23 (374)
Deferred grant revenue (12) (184)
Other accrued liabilities (514) (152)
Net cash used in operating activities (3,374) (4,846)
Cash flows from investing activities:    
Proceeds from sale of assets 228
Net cash provided by investing activities 228
Cash flows from financing activities:    
Net proceeds from issuance of preferred stock 9,094
Proceeds from short-term loans 750
Payments on short-term loans (250)
Net cash provided by financing activities 9,594
Net decrease in cash and restricted cash (3,374) 4,976
Cash and restricted cash at beginning of period 6,773 3,133
Cash and restricted cash at end of period 3,399 8,109
Supplemental cash flow information:    
Interest paid 13 4
Note payable to related party converted to common stock 500
Accrued interest net of tax converted to common stock 4
Disposal of fully depreciated property and equipment 711
Inventory transferred with sale of assets 106
Property and equipment, net, transferred with sale of assets 109
Notes receivable received in connection with sale of assets 1,500
Accounts payable related to sale of assets 17
Other accrued liabilities transferred with sale of assets 236
Cash 3,399 8,096
Restricted cash 13
Cash and restricted cash shown in the condensed statements of cash flows $ 3,399 $ 8,109

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL